EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

The prevalence of antibodies to reovirus type 3 in adults with idiopathic cholestatic liver disease


Journal of Medical Virology 16(1): 55-60
The prevalence of antibodies to reovirus type 3 in adults with idiopathic cholestatic liver disease
Sera from 22 adults with idiopathic cholestatic liver disease (16 primary biliary cirrhosis and six primary sclerosing cholangitis) were tested for antibody to Reovirus type 3 (Reo-3) virus by a standard hemagglutination inhibition assay. The results were compared to antibody prevalence in 10 adults with various other causes of chronic liver disease and 11 healthy volunteers. Although patients with idiopathic cholestatic liver disease had a high prevalence of anti Reo-3 antibodies (20/22. 91%), similar prevalence rates were found in the 2 control populations (7/10, 70% in chronic liver disease controls and 11/11, 10% in healthy volunteers). The geometric mean titers of antibody to Reo-3 virus were similar in all study groups. While the results do not exclude a pathogenetic role for Reo-3 viral infection, they do imply that some genetic predisposition must exist if Reo-3 infection is truly of pathogenetic importance in idiopathic cholestatic liverdisease of adults.

Accession: 006740219

PMID: 2995568

DOI: 10.1002/jmv.1890160108

Download PDF Full Text: The prevalence of antibodies to reovirus type 3 in adults with idiopathic cholestatic liver disease



Related references

Reovirus 3 not detected by reverse transcriptase-mediated polymerase chain reaction analysis of preserved tissue from infants with cholestatic liver disease. Hepatology 21(3): 697-702, 1995

Low prevalence of antibodies to hepatitis c virus in sera from patients with chronic cholestatic liver diseases. European Journal of Clinical Investigation 20(2 PART 2): A8, 1990

Prevalence of antibodies to formiminotransferase cyclodeaminase The target antigen of liver cytosol type 1 - in patients with autoimmune liver disease. Hepatology 36(4 Part 2): 504A, October, 2002

Idiopathic hypereosinophilic syndrome presenting as cholestatic liver disease. European Journal of Gastroenterology & Hepatology 9(8): 815-817, 1997

Recent developments in the management of idiopathic cholestatic liver disease. Annals of Gastroenterology 25(4): 317-326, 2012

Liver transplantation for chronic cholestatic liver disease in adults and children. Gastroenterology Clinics of North America 17(1): 145-155, 1988

Idiopathic adulthood ductopenia. A cause of chronic cholestatic liver disease and biliary cirrhosis. Journal of Hepatology 7(2): 193-199, 1988

Prevalence of subclinical vitamin K deficiency in cholestatic liver disease. Journal of Pediatric Gastroenterology and Nutrition 49(1): 78-84, 2009

High prevalence of celiac disease in autoimmune cholestatic liver disorders. Hepatology 36(4 Part 2): 493A, October, 2002

Vitamin e and neurologic function in adults with chronic cholestatic liver disease. Journal of the American College of Nutrition 6(5): 442, 1987